Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Sugammadex Monothiol Impurity
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Mono thio Sugammadex is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Mono thio Sugammadex usage and description
Mono thio Sugammadex is a novel drug used in the reversal of neuromuscular blockade induced by non-depolarizing neuromuscular blocking agents (NMBAs). The drug has unique properties that make it an ideal choice for rapid and effective reversal of neuromuscular blockade in surgical and anesthesia procedures. It is a modified form of Sugammadex, which is a cyclodextrin-based compound that selectively binds to NMBAs and rapidly reverses their effects.
Mono thio Sugammadex has a sulfhydryl group, which is responsible for its high affinity to certain NMBAs. It has been shown to be effective in reversing the effects of rocuronium, vecuronium, and pancuronium, which are commonly used NMBAs in clinical practice. The drug acts by encapsulating the NMBA molecule and forming a stable complex that can be easily eliminated from the body.
One of the advantages of Mono thio Sugammadex over other reversal agents is its rapid onset of action. It can reverse neuromuscular blockade within 2-3 minutes, which is significantly faster than other agents such as neostigmine. The drug also has a low incidence of adverse effects, making it a safe option for use in clinical practice.
In summary, Mono thio Sugammadex is a valuable drug for the reversal of neuromuscular blockade induced by certain NMBAs. Its unique properties make it an effective and safe option for use in surgical and anesthesia procedures.
